References
- El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17–26.
- Aanen MC, Weusten BLAM, Numans ME, de Wit NJ, Samsom M, Smout AJPM. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. J Clin Gastroenterol 2008;42:441–7.
- Ghillebert G, Demeyere AM, Janssens J, Vantrappen G. How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995;40:1317–24.
- Pandolfino JE, Richter JE, Ours T, Guardino JM. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003;98:740–9.
- Wong W, Bautista J, Dekel R, Malagon I, Tuchinsky I, Green C, Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring – a randomized trial. Aliment Pharmacol Ther 2005;21:155–63.
- Grigolon A, Bravi I, Cantù P, Conte D, Penagini R. Wireless pH monitoring: better tolerability and lower impact on daily habits. Dig Liver Dis 2007;39:720–4.
- Garrean CP, Zhang Q, Gonsalves N, Hirano I. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. Am J Gastroenterol 2008;103:1631–7.
- Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 2007;102:1–6.
- Maine I, Tutuian R, Castell DO. Comparison between the combined analysis and the DeMeester Score to predict response to PPI therapy. J Clin Gastroenterol 2006;40:602–5.
- Baldi F, Ferrarini F, Longanesi A, Bersani G. Ambulatory 24-hour oesophageal pH monitoring in normal subjects: a multicentre study in Italy. G.I.S.M.A.D. GOR Study Group. Ital J Gastroenterol 1991;23:477–80.
- Twisk JWR. Applied longitudinal data analysis for epidemiology. Cambridge: Cambridge University Press; 2003.
- Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008.
- Calabrese C, Liguori G, Gabusi V, Gionchetti P, Rizzello F, Straforini G. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. Aliment Pharmacol Ther 2008;28:250–5.
- Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398–402.
- Wenner J, Johansson J, Johnsson F, Oberg S. Optimal thresholds and discriminatory power of 48-h wireless esophageal pH monitoring in the diagnosis of GERD. Am J Gastroenterol 2007;102:1862–9.
- Wenner J, Johnsson F, Johansson J, Oberg S. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 2007;102:239–45.
- Revicki DA, Zodet MW, Joshua-Gotlib S, Levine D, Crawley JA. Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health Qual Life Outcomes 2003;29:73.
- Frankhuisen R, van Herwaarden MA, Heijkoop R, Smout AJ, Baron A, Vermeijden JR, Persisting symptoms and decreased health-related quality-of-life in a cross-sectional study of treated achalasia patients. Aliment Pharmacol Ther 2007;26:899–904.
- Armstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. Oxford: Oxford University Press; 1992.
- Jaspersen D, Labenz J, Willich SN, Kulig M, Nocon M, Leodolter A, Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis 2006;38:233–8.